Article · 27 May 2026
ArticlePublished 22 Jul 2016
A clinical update on the use of Resolute stents with dual anti-platelet therapy interruption
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Percutaneous coronary intervention is currently the most commonly used revascularization procedure. This success is a direct consequence of the improved medium- and long-term target vessel patency achieved with drug-eluting stents (DES). However, DES are associated with stent thrombosis (ST), a rare but potentially catastrophic complication. Early interruption of dual anti-platelet therapy (DAPT) is a major risk factor for ST and guidelines recommend a minimum duration of DAPT of 6 to 12 months post implantation. Recently published observational data suggest that premature DAPT interruption is not associated with ST in patients treated with the second-generation Resolute zotarolimus-eluting stent. This article reviews the background to the development of Resolute DES and reviews recently published data on ST and DAPT interruption.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Interventional Cardiology.
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “C OMahony”
- BylineArticles whose byline prints “M Rothman & A Mathur”